LCM
AMPE

Laurion Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Laurion Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-236
Closed -$241K – 1669
2018
Q1 		$241K Buy
+236
New +$198K ﹤0.01% 1188
2014
Q2 		– Sell
-418
Closed -$796K – 360
2014
Q1 		$796K Buy
+418
New +$988K 0.03% 181

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Laurion Capital Management's AMPE Position: Q2 2018 in Review

Laurion Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 236 shares — an estimated $241K sold.

Laurion Capital Management first reported a position in AMPE in Q1 2014 and held it in 2 quarters. The position peaked at $796K in Q1 2014. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

  • Laurion Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Laurion Capital Management sold 236 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $241K.
  • Laurion Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 2 quarters.
  • Laurion Capital Management's Ampio Pharmaceuticals Inc. position peaked at $796K in Q1 2014.
  • 86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Laurion Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.